Canada approves Moderna's RSV vaccine for adults aged 60 and older
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
Hosted on MSN1d
Moderna’s mRESVIA vaccine gains Health Canada approval
Moderna has received Health Canada's approval for its respiratory syncytial virus messenger ribonucleic acid (mRNA) ...
Times Colonist11h
Avian flu in humans: Pink eye a symptom, unclear if flu vaccine will offer protection
WILL THE FLU VACCINE PROTECT AGAINST H5N1 ... The Public Health Agency of Canada said as a general precaution, people ...
Do COVID-19 boosters still make sense? What to know about the latest vaccine rollout
Canada’s panel of vaccine advisers has strongly recommended the new vaccines targeting the KP.2 strain, part of the Omicron lineage, for the previously vaccinated or unvaccinated at increased risk ...
Morrison government’s $2 billion vaccine deal blasted
Australia’s audit office will probe the Morrison government’s $2 billion deal with US pharmaceutical giant Moderna to set up ...
Eagle-Tribune4d
Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older
mRESVIA is Moderna's second approved product in Canada, the first mRNA vaccine against RSV, and the only one in single-dose pre-filled syringes Canada is the fourth jurisdiction to approve ...
GlobalData on MSN6d
GSK’s RSV vaccine approved in Canada for adults aged 50 to 59
GlaxoSmithKline (GSK) has received approval for its vaccine, AREXVY, in Canada to prevent lower respiratory tract disease ...
Mpox vaccine doses divvied up for 9 African countries
The allocated vaccines are from European countries, the United States, Canada and Gavi, a public-private alliance that co-funds vaccine purchases for low-income countries. 2nd mpox vaccine dose ...